Literature DB >> 8917564

Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

E G Shesely1, N Maeda, H S Kim, K M Desai, J H Krege, V E Laubach, P A Sherman, W C Sessa, O Smithies.   

Abstract

Nitric oxide produced in endothelial cells affects vascular tone. To investigate the role of endothelial nitric oxide synthase (eNOS) in blood pressure regulation, we have generated mice heterozygous (+/-) or homozygous (-/-) for disruption of the eNOS gene. Immunohistochemical staining with anti-eNOS antibodies showed reduced amounts of eNOS protein in +/- mice and absence of eNOS protein in -/- mutant mice. Male or female mice of all three eNOS genotypes were indistinguishable in general appearance and histology, except that -/- mice had lower body weights than +/+ or +/- mice. Blood pressures tended to be increased (by approximately 4 mmHg) in +/- mice compared with +/+, while -/- mice had a significant increase in pressure compared with +/+ mice (approximately 18 mmHg) or +/- mice (approximately 14 mmHg). Plasma renin concentration in the -/- mice was nearly twice that of +/+ mice, although kidney renin mRNA was modestly decreased in the -/- mice. Heart rates in the -/- mice were significantly lower than in +/- or +/+ mice. Appropriate genetic controls show that these phenotypes in F2 mice are due to the eNOS mutation and are not due to sequences that might differ between the two parental strains (129 and C57BL/6J) and are linked either to the eNOS locus or to an unlinked chromosomal region containing the renin locus. Thus eNOS is essential for maintenance of normal blood pressures and heart rates. Comparisons between the current eNOS mutant mice and previously generated inducible nitric oxide synthase mutants showed that homozygous mutants for the latter differ in having unaltered blood pressures and heart rates; both are susceptible to lipopolysaccharide-induced death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917564      PMCID: PMC24066          DOI: 10.1073/pnas.93.23.13176

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Nitric oxide synthase activity is increased in patients with sepsis syndrome.

Authors:  H F Goode; P D Howdle; B E Walker; N R Webster
Journal:  Clin Sci (Lond)       Date:  1995-02       Impact factor: 6.124

2.  Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte.

Authors:  I G Charles; R M Palmer; M S Hickery; M T Bayliss; A P Chubb; V S Hall; D W Moss; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

3.  Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney.

Authors:  J Gardes; J M Poux; M F Gonzalez; F Alhenc-Gelas; J Menard
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

4.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  P L Huang; Z Huang; H Mashimo; K D Bloch; M A Moskowitz; J A Bevan; M C Fishman
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

6.  Genetic control of blood pressure and the angiotensinogen locus.

Authors:  H S Kim; J H Krege; K D Kluckman; J R Hagaman; J B Hodgin; C F Best; J C Jennette; T M Coffman; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Long-term cardiovascular role of nitric oxide in conscious rats.

Authors:  L Hu; R D Manning; M W Brands
Journal:  Hypertension       Date:  1994-02       Impact factor: 10.190

8.  Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.

Authors:  S W John; J H Krege; P M Oliver; J R Hagaman; J B Hodgin; S C Pang; T G Flynn; O Smithies
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

9.  A noninvasive computerized tail-cuff system for measuring blood pressure in mice.

Authors:  J H Krege; J B Hodgin; J R Hagaman; O Smithies
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

10.  Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.

Authors:  C Szabó; G J Southan; C Thiemermann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more
  292 in total

1.  Inhaled nitric oxide improves outcomes after successful cardiopulmonary resuscitation in mice.

Authors:  Shizuka Minamishima; Kotaro Kida; Kentaro Tokuda; Huifang Wang; Patrick Y Sips; Shizuko Kosugi; Joseph B Mandeville; Emmanuel S Buys; Peter Brouckaert; Philip K Liu; Christina H Liu; Kenneth D Bloch; Fumito Ichinose
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

2.  COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice.

Authors:  Dong Sun; Hong Liu; Changdong Yan; Azita Jacobson; Caroline Ojaimi; An Huang; Gabor Kaley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-21       Impact factor: 4.733

3.  The beta1 subunit of the Ca2+-sensitive K+ channel protects against hypertension.

Authors:  Mark T Nelson; Adrian D Bonev
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 4.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 5.  Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links.

Authors:  R D Rudic; W C Sessa
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

6.  Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis.

Authors:  Muzhou Wu; Stella E Tsirka
Journal:  Glia       Date:  2009-08-15       Impact factor: 7.452

7.  Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.

Authors:  Olena Andrukhova; Svetlana Slavic; Ute Zeitz; Sabine C Riesen; Monika S Heppelmann; Tamas D Ambrisko; Mato Markovic; Wolfgang M Kuebler; Reinhold G Erben
Journal:  Mol Endocrinol       Date:  2013-01-01

8.  Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle.

Authors:  Iman Momken; Dominique Fortin; Bernard Serrurier; Xavier Bigard; Renée Ventura-Clapier; Vladimir Veksler
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence.

Authors:  Amanda E Boe; Mesut Eren; Sheila B Murphy; Christine E Kamide; Atsuhiko Ichimura; David Terry; Danielle McAnally; Layton H Smith; Toshio Miyata; Douglas E Vaughan
Journal:  Circulation       Date:  2013-10-03       Impact factor: 29.690

10.  Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow.

Authors:  Doyon Won; Su-Ning Zhu; Mian Chen; Anouk-Martine Teichert; Jason E Fish; Charles C Matouk; Michael Bonert; Matadial Ojha; Philip A Marsden; Myron I Cybulsky
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.